Skip to main content

Table 2 Intraprocedural and In-hospital data (Mean ± SD)

From: Early experience with ovation endograft system in abdominal aortic disease

  n = 37
Anesthesia  
Regional 25 (67.6%)
Local + conscious sedation 7 (18.9%)
General 5 (13.5%)
Vascular access  
Percutaneous femoral 27 (73%)
Percutaneous brachial (additional) 2 (5.4%)
Surgical femoral 10 (27%)
Time of operation (min) 43.1 ± 3.2
Amount of contrast (cc) 28.3 ± 2.5
Fluoroscopy time (min) 11.3 ± 1.5
Blood loss (cc) 110 ± 16
Primary success 33 (89.2%)
Adjunctive procedure* 4 (10.8%)
Length of stay (days) 3.6 ± 0.9
30-day results  
Death 0 (0%)
Major adverse events 0 (0%)
Endoleak 0 (0%)
Long-term results  
Death 0 (0%)
Major adverse events 0 (0%)
Endoleak type II 2 (5.4%)
Asintomatic narrowing of iliac limbs 1 (2.8%)
  1. Thirty-day and long-term results.
  2. *two distal extensions (type 1b endoleak and iliac limb disconnection resulting in type III endoleak) and two bypass surgeries (limb graft occlusion and gate cannulation failure).